Assessment of a United States pharmaceutical care model for nursing homes in the United Kingdom

Pharmacy World and Science

Volumn 29, Issue 5, 2007, Pages 517-525

  Patterson, Susan M ^a   Hughes, Carmel M ^a   Lapane, Kate L ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BROWN UNIVERSITY   (United States)

Author keywords

Nursing homes; Pharmaceutical care; Prescribing; Qualitative research; United Kingdom

Indexed keywords

HYPNOTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HUMAN; MALE; MANAGER; MEDICAL RECORD; NURSING HOME; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PHARMACIST; PRESCRIPTION; RECORDING; SEMI STRUCTURED INTERVIEW; UNITED KINGDOM; UNITED STATES;

AGED; DATA COLLECTION; FEMALE; FOCUS GROUPS; GREAT BRITAIN; HUMANS; MALE; NURSING HOMES; PHARMACEUTICAL SERVICES; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL ROLE; UNITED STATES;

EID: 34548599615     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9044-4     Document Type: Article

References (31)

1. Elon R, Pawlson LG. The impact of OBRA on medical practices within nursing facilities. J Am Geriatr Soc 1992;40:958-63
2. Hughes CM, Lapane K, Mor V. The impact of legislation on nursing home care in the United States: lessons for the United Kingdom. BMJ 1999;319:1060-3
3. Institute of Medicine. Improving the quality of care in nursing homes. Washington, DC; National Academy Press. 1986; ISBN: 0309078873
4. Rovner BW, Edelman BA, Cox MP, Shmuely Y. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 1992;149:1390-2
5. Semla TP, Palla K, Poddig B, Brauner DJ. Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. J Am Geriatr Soc 1994;42:648-52
6. Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA 1994;271:358-63
7. Garrard J, Chen V, Dowd B. The impact of the 1987 Federal regulations on the use of psychotropic drugs in Minnesota nursing homes. Am J Pub Health 1995;85:771-6
8. Hughes CM, Lapane KL, Mor V, Ikegami I, Jonsson PV, Ljunggren G et al. The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. J Am Geriatr Soc 2000;48:931-7
9. Bernabei R, Gambassi G, Lapane KL, Landi F, Gatosnis C, Dunlop R et al. Management of pain in elderly patients with cancer. JAMA 1998;279:1877-82
10. Lapane KL, Barbour MM, Van Haaren A, Gambassi G. Anti-ischemic therapy in patients with coronary heart disease living in long term care. Pharmacotherapy 1999;19:627-34
11. Gambassi G, Forman DE, Lapane KL. Management of heart failure among very old individuals living in long-term care: has the voice of trials spread? Am Heart J 2000;139:85-93
12. Spooner JJ, Lapane KL, Hume AL, Mor V, Gambassi G. Pharmacologic treatment of diabetes in long term care. J Clin Epi 2001;54:525-30
13. Office of Inspector General. Prescription drug use in nursing homes. Report no. OEI-069600081; 1997
14. Cameron K, Feinberg JL, Lapane KL. Fleetwood project Phase III moves forward. Consultant Pharmacist 2002;17:181-98
15. Fahey T, Montgomery AA, Barnes J, Protheroe J. Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. BMJ 2003;326:580-4
16. McGrath AM, Jackson GA. Survey of neuroleptic prescribing in residents of nursing homes in Glasgow. BMJ 1996;312:611-2
17. Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T et al. Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. BMJ 2002;325:766-70
18. Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial. BMJ 2002;325:415-9
19. Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ 2000;320:114-6
20. Schweizer AK, Hughes CM. Nursing and residential care for the elderly: the contribution of the pharmacist. Pharm World Sci 2001;23:195-9
21. Schweizer AK, Hughes CM. Providing pharmacy services to care homes in Northern Ireland: a survey of community pharmacists' views. Pharm World Sci 2004;26:346-52
22. Greenhalgh T, Collard A, Begum N. Sharing stories: complex interventions for diabetes education in minority ethnic groups who do not speak English. BMJ 2005;330:628-33
23. Medical Research Council. A framework for development and evaluation of RCTs for complex interventions to improve health. London; Medical Research Council. 2000
24. Hughes CM. Long-term care of the elderly: challenges in pharmaceutical care. J Soc Admin Pharm 2000;17:66-70
25. Hendrichs J, Hovel G, Lohbreier-Dorr J, Pardieck A, Puteanus U. Drug supply to nursing homes for the aged. Gesundheitswesen 2001;63:514-21
26. Spong L. Role of the pharmacist in nursing homes in northern Europe. Pharm J 1992;249:23-5
27. Boockvar K, Fishman E, Kyriacou CK, Monias A, Gavi S, Costes T. Adverse events due to discontinuations in drug use and dose changes in patients transferred between acute and long-term care facilities. Arch Intern Med 2004;164:545-50
28. Ouslander JG, Fitzler S, Roadman CH, Minnix WL, MacLaughlin Frandsen B et al. Accuracy (or lack thereof) of nursing home medical records: what do industry and professional organisations have to say? J Am Geriatr Soc 2004;52:1395-8
29. Midlov P, Bergkvist A, Bondesson A, Eriksson T, Hoglund P. Medication errors when transferring elderly patients between primary health care and hospital care. Pharm World Sci 2005;27:116-20
30. Hughes CM, Turner K, Fitzpatrick C, Linton A, Laird T. The use of a prescribing audit tool to assess the impact of a practice pharmacist in general practice. Pharm J 1999;262:27-30
31. Hughes CM, O'Neill S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract 2003;53:600-6